Literature DB >> 18666339

Nutritional therapy for active Crohn's disease.

Paul-A Smith.   

Abstract

Nutritional therapy for active Crohn's disease (CD) is an underutilised form of treatment in adult patients, though its use is common in the paediatric population. There is evidence that nutritional therapy can effectively induce remission of CD in adult patients. Enteral nutrition therapy is safe and generally well tolerated. Meta-analysis data suggest that corticosteroids are superior to nutritional treatment for induction of remission in active CD. However, the potential side effects of such pharmacotherapy must be taken into consideration. This review examines the evidence for the efficacy of elemental and polymeric diets, and the use of total parenteral nutrition in active CD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666339      PMCID: PMC2731202          DOI: 10.3748/wjg.14.4420

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

Review 1.  Formulation of enteral diets.

Authors:  D B Silk
Journal:  Nutrition       Date:  1999 Jul-Aug       Impact factor: 4.008

2.  Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial.

Authors:  Osvaldo Borrelli; Letizia Cordischi; Manuela Cirulli; Massimiliano Paganelli; Valeria Labalestra; Stefania Uccini; Paolo M Russo; Salvatore Cucchiara
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-06       Impact factor: 11.382

Review 3.  Enteral nutritional therapy for induction of remission in Crohn's disease.

Authors:  M Zachos; M Tondeur; A M Griffiths
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach.

Authors:  Andrew S Day; Kylie E Whitten; Daniel A Lemberg; Cathy Clarkson; Maribel Vitug-Sales; Reuben Jackson; Tim D Bohane
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

5.  Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone.

Authors:  D A Gorard; J B Hunt; J J Payne-James; K R Palmer; R G Rees; M L Clark; M J Farthing; J J Misiewicz; D B Silk
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

6.  The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease.

Authors:  K Teahon; P Smethurst; M Pearson; A J Levi; I Bjarnason
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

7.  Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial.

Authors:  F González-Huix; R de León; F Fernández-Bañares; M Esteve; E Cabré; D Acero; A Abad-Lacruz; M Figa; M Guilera; R Planas
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  Controlled trial of bowel rest and nutritional support in the management of Crohn's disease.

Authors:  G R Greenberg; C R Fleming; K N Jeejeebhoy; I H Rosenberg; D Sales; W J Tremaine
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

9.  Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

Authors:  M A Gassull; F Fernández-Bañares; E Cabré; M Papo; M H Giaffer; J L Sánchez-Lombraña; C Richart; H Malchow; F González-Huix; M Esteve
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 10.  Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications.

Authors:  Joachim Mankertz; Jörg-Dieter Schulzke
Journal:  Curr Opin Gastroenterol       Date:  2007-07       Impact factor: 3.287

View more
  7 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

Review 2.  Wound healing of intestinal epithelial cells.

Authors:  Masahiro Iizuka; Shiho Konno
Journal:  World J Gastroenterol       Date:  2011-05-07       Impact factor: 5.742

Review 3.  New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease.

Authors:  Darla R Shores; David G Binion; Bruce A Freeman; Paul R S Baker
Journal:  Inflamm Bowel Dis       Date:  2010-12-03       Impact factor: 5.325

Review 4.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 5.  The role of enteral nutrition in patients with inflammatory bowel disease: current aspects.

Authors:  John K Triantafillidis; Costas Vagianos; Apostolos E Papalois
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

6.  Safety and Efficacy of Exclusive Enteral Nutrition for Percutaneously Undrainable Abdominal Abscesses in Crohn's Disease.

Authors:  Yibin Zhu; Liang Xu; Wei Liu; Weilin Qi; Qian Cao; Wei Zhou
Journal:  Gastroenterol Res Pract       Date:  2017-08-30       Impact factor: 2.260

7.  Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses.

Authors:  Kenji Watanabe; Satoshi Motoya; Haruhiko Ogata; Takanori Kanai; Toshiyuki Matsui; Yasuo Suzuki; Mitsuhiro Shikamura; Kenkichi Sugiura; Kazunori Oda; Tetsuharu Hori; Takahiro Araki; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2019-12-13       Impact factor: 7.527

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.